This series on “Recent Advances in Neuro-Oncology” is edited by Dr. Wenyin Shi (from Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, USA), Dr. Joshua D Palmer (from Department of Radiation Oncology, Ohio State University, Columbus, USA), Dr. Iyad Alnahhas (from Department of Neurology and Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, USA).
Emerging insights on management of high-grade glioma
Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment
Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review
Tumor treating fields with radiation for glioblastoma: a narrative review
Radiotherapy for elderly patients with glioblastoma: an assessment of hypofractionation and modern treatment techniques
Efficacy of scalp-sparing volumetric-modulated arc therapy approach in reducing scalp radiation dose for patients with glioblastoma: a cross-sectional study
Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial
Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review
Proton radiotherapy for glioma and glioblastoma
2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review
Disclosure:
The series “Recent Advances in Neuro-Oncology” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Dr. Wenyin Shi, Dr. Joshua D Palmer and Dr. Iyad Alnahhas served as the unpaid Guest Editors for the series.